Paper: Comparing the Efficacy and Safety of Venetoclax Combined with Decitabine Versus Conventional Chemotherapy As Induction Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia – Interim Analysis of a Multicenter, Randomized, Phase 2b Trial
Program: Oral and Poster Abstracts Type: Oral Session: 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Improving Intensive Chemotherapy Regimens for Treatment of AML Hematology Disease Topics & Pathways: Non-Biological therapies, Chemotherapy, Therapies Jing Lu, MD 1 *, Shengli Xue 2 *, Ying Wang 2 *, Hai-Ping Dai 2 *, Xuefeng He 2 *, Xiaohui Hu 2 *, Miao Miao 2 *, Huiying Qiu 2 *, Han Yue 2 *, Caixia Li 2 *, Depei Wu 2 and Suning